OrbiMed Advisors Picked Viewray Inc. (NASDAQ:VRAY) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC),...
Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more

trending

BTTX Stock Price is up 23%, can it go higher? URGENT
Five Prime Therapeutics (NASDAQ: FPRX) Hits New High...
Farallon Capital is Buying Radius Health Inc. (NASDA...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Viewray Inc. (NASDAQ:VRAY) reported that OrbiMed Advisors has picked up 9,866,102 of common stock as of 2017-03-21.

The acquisition brings the aggregate amount owned by OrbiMed Advisors to a total of 9,866,102 representing a 17.7% stake in the company.

For those not familiar with the company, ViewRay, Inc. designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered. MRIdian delivers radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian provides real-time imaging that defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment. MRIdian allows physicians to record the level of radiation exposure that the tumor has received and adapt the prescription between fractions as needed.

A glance at Viewray Inc. (NASDAQ:VRAY)’s key stats reveals a current market capitalization of 377.33 million based on 38.23 Million shares outstanding and a price at last close of $7.16 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2017-01-18, Bansal picked up 62,597 at a purchase price of $3.17. This brings their total holding to 70,104 as of the date of the filing.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Viewray Inc. (NASDAQ:VRAY) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Stay in the lopp :

Sunshine Heart Inc. (NASDAQ:SSH) Attracts Yet...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Sunshine Heart Inc. (NASDAQ:SSH) reported that Talu Ventures Pty Ltd
Grove Inc. GRVI Stock Price is BULLISH, &...

Grove Inc GRVI stock price is up 28% in the last 3 months and it appears that it is just the

P2 Capital Partners Picked Up Forrester Resea...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Forrester Research Inc. (NASDAQ:FORR) reported that P2 Capital Partners has

related post

Skip to content